Fieldview Capital Management, LLC Bio Techne Corp Call Options Transaction History
Fieldview Capital Management, LLC
- $708 Billion
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding TECH
# of Institutions
628Shares Held
160MCall Options Held
90KPut Options Held
14.2K-
Vanguard Group Inc Valley Forge, PA18.5MShares$918 Million0.02% of portfolio
-
Black Rock Inc. New York, NY15MShares$742 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD11.4MShares$563 Million0.08% of portfolio
-
State Street Corp Boston, MA6.53MShares$323 Million0.02% of portfolio
-
Morgan Stanley New York, NY5.72MShares$283 Million0.02% of portfolio
About BIO-TECHNE Corp
- Ticker TECH
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 39,222,600
- Market Cap $1.94B
- Description
- Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...